Skip to the page

Data / Federal rules / 2024-21932

Microbiology Devices; Reclassification of Antigen, Antibody, and Nucleic Acid-Based Hepatitis B Virus Assay Devices

The Food and Drug Administration published this proposed rule in the Federal Register on September 25, 2024. Comments closed on November 25, 2024.

SpecStream is the live web data engine for teams and agents. It reads every rule and proposed rule in the Federal Register each morning, and this page is that reading. Name your industry once and new rules, comment deadlines and effective dates arrive in your sheet, CRM, Slack or agent as they are published.

What the agency says

The Food and Drug Administration (FDA, the Agency, or we) is proposing to reclassify qualitative hepatitis B virus (HBV) antigen assays, qualitative HBV antibody assays and quantitative assays that detect anti-HBs (antibodies to HBV surface antigen (HBsAg)), and quantitative HBV nucleic acid-based assays, all of which are postamendments class III devices, into class II (general controls and special controls), subject to premarket notification. FDA is also proposing three new device classification regulations along with the special controls that the Agency believes are necessary to provide a reasonable assurance of safety and effectiveness for each device.

Key facts

Document number
2024-21932
Type
Proposed rule
Action
Proposed amendment; proposed order; request for comments
Agency
Health and Human Services Department; Food and Drug Administration
Published
September 25, 2024
Comments due
November 25, 2024
Dates
Either electronic or written comments on the proposed order must be submitted by November 25, 2024. Please see section X of this document for the proposed effective date when the new requirements apply and for the proposed effective date of a final order based on this proposed order.
Docket
Docket No. FDA-2024-N-3533
Code of Federal Regulations
21 CFR 866
Topics
Biologics; Laboratories; Medical devices
Pages
14

The document on federalregister.gov PDF

Other documents from the Food and Drug Administration

Everything from the Food and Drug Administration · Rules on biologics · Rules on laboratories · Rules on medical devices · Published in September 2024

Read from the Federal Register API, last updated 2026-10-23. The document on federalregister.gov is the official record; dates and dockets can change through later corrections. Free to reuse with credit to SpecStream under CC BY 4.0.